Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tedizolid Phosphate DDI with Midazolam and Rosuvastatin
NCT02477514Phase 1Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of tedizolid, sponsored by Merck & Co. Primary endpoints: Area under the concentration versus time curve from 0 to last observed concentration at Day 14, Area under the concentration versus time curve from 0 to infinity at Day 14 and 1 more. Started Jun 2015; status: completed.
02
Drugs
tedizolid
Beyond the preview
Go deeper on NCT02477514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477514.